Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Leerink
Recent news which mentions Leerink
< Previous
1
2
3
4
5
Next >
Gilead Analyst: Coronavirus Drug, Arcus Collaboration Make Biopharma A Buy
June 03, 2020
Tickers
GILD
RCUS
Tags
Benzinga
remdesivir
Coronavirus
From
Benzinga
6 Gene Therapy M&A Targets On The Radar
March 27, 2019
Tickers
BIIB
BMRN
BOLD
CELG
Tags
BOLD
SLDB
Market News
From
Benzinga
Leerink Starts Coverage Of Genetic Medicine Stocks: 'We See Commercial Execution As Increasingly Driving Returns'
November 28, 2018
Tickers
ALNY
AVRO
BLUE
DRNA
Tags
Biotech
General
IONS
From
Benzinga
Leerink Out Bullish On GW Pharma: 4 Reasons Why
November 14, 2018
Tickers
CBD
GWPH
Tags
CBD
medical marijuana
Cannabis
From
Benzinga
Leerink: Improving Fundamentals Drive Teva Upgrade
October 01, 2018
Tickers
AMGN
LLY
TEVA
Tags
Ami Fadia
Leerink
Benzinga
From
Benzinga
Leerink Upgrades Mednax On Margin Expansion, Share Gains And Valuation
September 24, 2018
Tickers
MD
Tags
MD
Benzinga
Analyst Ratings
From
Benzinga
Leerink: Translate Bio's Cystic Fibrosis Candidate Could Generate $1.8B
July 23, 2018
Tickers
TBIO
Tags
Price Target
Market News
Analyst Color
From
Benzinga
Wall Street Analysts Reflect On AT&T-Time Warner Ruling, Assess Implications Outside Tech, Media
June 13, 2018
Tickers
AAPL
AET
AMZN
CHTR
Tags
CI
Deutsche Bank
TMUS
From
Benzinga
Analysts Roar Praise For Aslan, But Leerink More Tepid
May 30, 2018
Tickers
ASLN
Tags
Analyst Color
Biotech
Price Target
From
Benzinga
Leerink Downgrades Hologic After 'Lower Quality' Q2 Revenue Beat
May 03, 2018
Tickers
HOLX
Tags
Benzinga
Cynosure
Health
From
Benzinga
Leerink Upgrades Mylan On Barrage Of Catalysts, Diversified Platforms
April 12, 2018
Tickers
MYL
Tags
Health Care
Neulasta
Advair
From
Benzinga
Leerink's Takeaways From CNBC's 'Healthy Returns' Conference
March 31, 2018
Tickers
AMZN
CI
NEWS
RDUS
Tags
General
Analyst Ratings
Ana Gupte
From
Benzinga
Leerink: Armo Biosciences' 'Promising' Data Justifies A Bullish Stance
March 27, 2018
Tickers
ARMO
Tags
Biotech
Immuno Oncology
AM0010
From
Benzinga
Why Leerink Adjusted Upside Expectations For 3 Biotechs
February 23, 2018
Tickers
BMRN
TFX
ZGNX
Tags
General
TFX
Analyst Ratings
From
Benzinga
AbbVie Shares Double In A Year; Leerink Moves To Sidelines
January 29, 2018
Tickers
ABBV
ALXN
CELG
REGN
Tags
Analyst Ratings
Geoffrey Porges
ABBV
From
Benzinga
Leerink: Bluebird Bio's Catalysts Are Priced In
January 25, 2018
Tickers
BLUE
Tags
Leerink Swann
Downgrades
Leerink
From
Benzinga
What Wall Street Thinks Of The $69 Billion CVS-Aetna Deal
December 04, 2017
Tickers
AET
AMZN
CVS
ESRX
Tags
Citi
Benzinga
M&A
From
Benzinga
Neurocrine Biosciences Exceeds Expectations With Ingrezza Launch
November 02, 2017
Tickers
NBIX
TEVA
Tags
Benjamin Burnett
General
Analyst Ratings
From
Benzinga
Buy Thermo Fisher On Amazon Fear-Inspired Dip
October 30, 2017
Tickers
AMZN
TMO
Tags
health care
Long Ideas
pharmacy
From
Benzinga
Express Scripts: Another Potential Amazon Victim?
October 10, 2017
Tickers
AMZN
CVS
ESRX
NEWS
Tags
Technicals
Rumors
Analyst Color
From
Benzinga
Amazon Could Partner With UnitedHealth For Pharmacy Unit By Thanksgiving
October 09, 2017
Tickers
AMZN
CVS
ESRX
NEWS
Tags
AMZN
Analyst Color
Rumors
From
Benzinga
Analyst: Amazon's Entry Into Pharmacy Is All But Certain At This Point
October 06, 2017
Tickers
AMZN
CVS
ESRX
HUM
Tags
Analyst Color
AMZN
Top Stories
From
Benzinga
Selling The News In Acadia Pharmaceuticals
October 06, 2017
Tickers
ACAD
NEWS
Tags
FDA
Adam Feuerstein
pirmavarserin
From
Benzinga
Pros And Cons Of All The News Out Of Acadia Pharma This Week
October 06, 2017
Tickers
ACAD
NEWS
Tags
General
Analyst Ratings
Paul Matteis
From
Benzinga
There's Good Cause To Be Excited About Amicus Therapeutics Clinical Program
October 04, 2017
Tickers
FOLD
Tags
Benzinga
Analyst Ratings
FOLD
From
Benzinga
What's The Thesis On ProQR Now, After Promising Phase 1 Data?
September 26, 2017
Tickers
NEWS
PRQR
Tags
News
Leerink
Biopharmaceutical
From
Benzinga
43% Upside Seen For Dova Pharma Following Competitor Product's Poor Results
September 26, 2017
Tickers
DOVA
Tags
avatrombopag
Lusutrombopag
Biotech
From
Benzinga
The Street Has Finally Recognized The Exelixis Clinical Program Potential
September 22, 2017
Tickers
AVEO
BMY
EXEL
PFE
Tags
AVEO
EXEL
Varun Kumar
From
Benzinga
Gilead Sciences: Is The Kite Deal Too Little, Too Late?
September 18, 2017
Tags
drug makers
Gilead Sciences
Leerink
From
Stocks to Watch
Mirati Therapeutics Sitravatinib Data, Explained
September 15, 2017
Tickers
BMY
MRTX
Tags
MRTX
Varun Kumar
Opdivo
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.